Impact of COVID-19 on Antimicrobial Use and Antimicrobial Resistance

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    University of Minnesota
  • Principal Investigator

    DVM. Randall Singer
  • Research Location

    United States of America
  • Lead Research Institution

    College of Veterinary Medicine, University of Minnesota
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Environmental stability of pathogen

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Led by Randall Singer, DVM, PhD, professor of epidemiology, College of Veterinary Medicine, and co-leads Irene Bueno, DVM, MPH, PhD, and Bill Arnold, PhD, researchers in this study will conduct environmental sampling of water to quantify antimicrobial concentrations and antimicrobial resistant bacteria that are relevant to human health. They will also obtain antibiotic use data at the major Minnesota hospitals and correlate these data with the environmental sampling results. "Antimicrobials are not entirely metabolized by humans after administration, and wastewater treatment plants cannot completely remove antimicrobials during the treatment process. In addition, antimicrobial resistant bacteria may also survive and even be concentrated by wastewater treatment," said Singer. "Thus, the natural environment can serve as a proxy of antimicrobial usage and antimicrobial resistance changes in the human population."